{"pmid":32320091,"title":"Dermatologists and SARS-CoV-2: The impact of the pandemic on daily practice.","text":["Dermatologists and SARS-CoV-2: The impact of the pandemic on daily practice.","Since the first case of \"pneumonia of unknown aetiology\" was diagnosed at the Wuhan Jinyintan Hospital in China on 30 December 2019, what was recognised thereafter as \"severe acute respiratory syndrome coronavirus 2\" (SARS-CoV-2) has spread over the four continents, causing the respiratory manifestations of Coronavirus disease-19 (COVID- 19) and satisfying the epidemiological criteria for a label of \"pandemic.\" The ongoing SARS-CoV-2 pandemic is having a huge impact on dermatological practice including the marked reduction of face-to-face consultations in favour of teledermatology, the uncertainties concerning the outcome of COVID-19 infection in patients with common inflammatory disorders such as psoriasis or atopic dermatitis receiving immunosuppressive/immunomodulating systemic therapies; the direct involvement of dermatologists in COVID-19 care for patients assistance and new research needs to be addressed. It is not known yet, if skin lesions and derangement of the skin barrier could make it easier for SARS-CoV-2 to transmit via indirect contact; it remains to be defined if specific mucosal or skin lesions are associated with SARS-CoV-2 infection, although some unpublished observations indicate the occurrence of a transient varicelliform exanthema during the early phase of the infection. SARS-CoV-2 is a new pathogen for humans that is highly contagious, can spread quickly, and is capable of causing enormous health, economic and societal impacts in any setting. The consequences may continue long after the pandemic resolves, and new management modalities for dermatology may originate from the COVID-19 disaster. Learning from experience may help to cope with future major societal changes.","J Eur Acad Dermatol Venereol","Gisondi, P","Piaserico, S","Conti, A","Naldi, L","32320091"],"abstract":["Since the first case of \"pneumonia of unknown aetiology\" was diagnosed at the Wuhan Jinyintan Hospital in China on 30 December 2019, what was recognised thereafter as \"severe acute respiratory syndrome coronavirus 2\" (SARS-CoV-2) has spread over the four continents, causing the respiratory manifestations of Coronavirus disease-19 (COVID- 19) and satisfying the epidemiological criteria for a label of \"pandemic.\" The ongoing SARS-CoV-2 pandemic is having a huge impact on dermatological practice including the marked reduction of face-to-face consultations in favour of teledermatology, the uncertainties concerning the outcome of COVID-19 infection in patients with common inflammatory disorders such as psoriasis or atopic dermatitis receiving immunosuppressive/immunomodulating systemic therapies; the direct involvement of dermatologists in COVID-19 care for patients assistance and new research needs to be addressed. It is not known yet, if skin lesions and derangement of the skin barrier could make it easier for SARS-CoV-2 to transmit via indirect contact; it remains to be defined if specific mucosal or skin lesions are associated with SARS-CoV-2 infection, although some unpublished observations indicate the occurrence of a transient varicelliform exanthema during the early phase of the infection. SARS-CoV-2 is a new pathogen for humans that is highly contagious, can spread quickly, and is capable of causing enormous health, economic and societal impacts in any setting. The consequences may continue long after the pandemic resolves, and new management modalities for dermatology may originate from the COVID-19 disaster. Learning from experience may help to cope with future major societal changes."],"journal":"J Eur Acad Dermatol Venereol","authors":["Gisondi, P","Piaserico, S","Conti, A","Naldi, L"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32320091","week":"202017|Apr 20 - Apr 26","doi":"10.1111/jdv.16515","source":"PubMed","topics":["Prevention"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664815087646408705,"score":8.518259,"similar":[{"pmid":32314460,"title":"Challenges of Covid-19 Pandemic for Dermatology.","text":["Challenges of Covid-19 Pandemic for Dermatology.","SARS-CoV-2 is a new corona virus responsible for the pandemic named Coronavirus Disease 2019 (COVID-19). The disease causes severe acute respiratory syndromes with a significant morbidity and mortality. We provide a review with a focus on COVID-19 in dermatology. We discuss triage of suspected infectious patients, protection of medical doctors and nurses. We discuss the available data on cutaneous symptoms, although disease-specific symptoms have yet not been observed. COVID-19 is a challenge for the treatment of dermatologic patients, either with severe inflammatory disorders or with skin cancer. The consequences for systemic treatment are obvious but it will be most important to collect the clinical data for a better decision process. Last but not least education in dermatology for students will be temporarily not be possible in the classical settings. COVID-19, although not a skin disease by itself has an immense impact on dermatology. This article is protected by copyright. All rights reserved.","Dermatol Ther","Wollina, Uwe","32314460"],"abstract":["SARS-CoV-2 is a new corona virus responsible for the pandemic named Coronavirus Disease 2019 (COVID-19). The disease causes severe acute respiratory syndromes with a significant morbidity and mortality. We provide a review with a focus on COVID-19 in dermatology. We discuss triage of suspected infectious patients, protection of medical doctors and nurses. We discuss the available data on cutaneous symptoms, although disease-specific symptoms have yet not been observed. COVID-19 is a challenge for the treatment of dermatologic patients, either with severe inflammatory disorders or with skin cancer. The consequences for systemic treatment are obvious but it will be most important to collect the clinical data for a better decision process. Last but not least education in dermatology for students will be temporarily not be possible in the classical settings. COVID-19, although not a skin disease by itself has an immense impact on dermatology. This article is protected by copyright. All rights reserved."],"journal":"Dermatol Ther","authors":["Wollina, Uwe"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314460","week":"202017|Apr 20 - Apr 26","doi":"10.1111/dth.13430","keywords":["covid-19 pandemic","dermatology","sars-cov-2"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664714520054988800,"score":188.39165},{"pmid":32330324,"title":"Acral cutaneous lesions in the Time of COVID-19.","text":["Acral cutaneous lesions in the Time of COVID-19.","Coronavirus disease 2019 (COVID-19) has become a pandemic condition, yet little is known about its dermatologic manifestations. We report here on peculiar (perniosis-like) skin lesions, unreported in the previous years, observed in young outpatients visited in our Dermatologic Unit in the last 4 weeks of COVID-19 pandemic (March-April 2020). Similar cases were referred to us in the same period by Pediatricians and Dermatologists from Italy and European countries.","J Eur Acad Dermatol Venereol","Recalcati, S","Barbagallo, T","Frasin, L A","Prestinari, F","Cogliardi, A","Provero, M C","Dainese, E","Vanzati, A","Fantini, F","32330324"],"abstract":["Coronavirus disease 2019 (COVID-19) has become a pandemic condition, yet little is known about its dermatologic manifestations. We report here on peculiar (perniosis-like) skin lesions, unreported in the previous years, observed in young outpatients visited in our Dermatologic Unit in the last 4 weeks of COVID-19 pandemic (March-April 2020). Similar cases were referred to us in the same period by Pediatricians and Dermatologists from Italy and European countries."],"journal":"J Eur Acad Dermatol Venereol","authors":["Recalcati, S","Barbagallo, T","Frasin, L A","Prestinari, F","Cogliardi, A","Provero, M C","Dainese, E","Vanzati, A","Fantini, F"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330324","week":"202017|Apr 20 - Apr 26","doi":"10.1111/jdv.16533","keywords":["covid-19","acral lesions","children","cutaneous manifestations","pediatric population","skin"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Pediatricians","Dermatologists","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"_version_":1664996914780700672,"score":186.91566},{"pmid":32294265,"title":"Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in sardinia (Italy).","text":["Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in sardinia (Italy).","Psoriasis is a major chronic inflammatory skin disease, affecting about 3% of the population in Italy, whose management require experienced specialists in order to guarantee high-quality standards of care. The pandemic coronavirus (2019-nCoV; COVID-19) has changed the approach to all patients requiring close contact during a visit, including dermatologic consultations. In Italy, true outbreak begun in Lombardy, by February 21, 2020 with exponential contagion, surpassing China in the number of deaths.","J Eur Acad Dermatol Venereol","Atzori, L","Mugheddu, C","Addis, G","Sanna, S","Satta, R","Ferreli, C","Atzori, M G","Montesu, M A","Rongioletti, F","32294265"],"abstract":["Psoriasis is a major chronic inflammatory skin disease, affecting about 3% of the population in Italy, whose management require experienced specialists in order to guarantee high-quality standards of care. The pandemic coronavirus (2019-nCoV; COVID-19) has changed the approach to all patients requiring close contact during a visit, including dermatologic consultations. In Italy, true outbreak begun in Lombardy, by February 21, 2020 with exponential contagion, surpassing China in the number of deaths."],"journal":"J Eur Acad Dermatol Venereol","authors":["Atzori, L","Mugheddu, C","Addis, G","Sanna, S","Satta, R","Ferreli, C","Atzori, M G","Montesu, M A","Rongioletti, F"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32294265","week":"202016|Apr 13 - Apr 19","doi":"10.1111/jdv.16473","keywords":["covid-19","coronavirus pandemic","dermatology","psoriasis"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Italy","Italy","Lombardy","China","sardinia","Italy"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"_version_":1664636192581222401,"score":178.53531},{"pmid":32223004,"title":"Art of performing dermoscopy during the times of coronavirus disease (COVID-19): Simple change in approach can save the day!","text":["Art of performing dermoscopy during the times of coronavirus disease (COVID-19): Simple change in approach can save the day!","Dermatoscope is a convenient diagnostic tool used by dermatologists in the diagnosis of skin, hair and nail disorders. During dermoscopy, a dermatoscope comes in contact with the patient and hence can act as a potential source of nosocomial spread of infections.(1) The uncertainty associated with the mode of spread of current coronavirus disease (COVID-19) has only lead to confusion and studies are underway to determine the role of zoonotic and environmental factors.(2-4) There are reports of presence of severe acute respiratory syndrome coronavirus (SARS-CoV-2) on door handles, mobile phones and other surfaces.","J Eur Acad Dermatol Venereol","Jakhar, Deepak","Kaur, Ishmeet","Kaul, Subuhi","32223004"],"abstract":["Dermatoscope is a convenient diagnostic tool used by dermatologists in the diagnosis of skin, hair and nail disorders. During dermoscopy, a dermatoscope comes in contact with the patient and hence can act as a potential source of nosocomial spread of infections.(1) The uncertainty associated with the mode of spread of current coronavirus disease (COVID-19) has only lead to confusion and studies are underway to determine the role of zoonotic and environmental factors.(2-4) There are reports of presence of severe acute respiratory syndrome coronavirus (SARS-CoV-2) on door handles, mobile phones and other surfaces."],"journal":"J Eur Acad Dermatol Venereol","authors":["Jakhar, Deepak","Kaur, Ishmeet","Kaul, Subuhi"],"date":"2020-03-31T11:00:00Z","year":2020,"_id":"32223004","week":"202014|Mar 30 - Apr 05","doi":"10.1111/jdv.16412","keywords":["COVID-19","coronavirus disease","cross infection","dermatoscope","dermoscopy","nosocomial spread"],"source":"PubMed","topics":["Transmission","Prevention"],"weight":1,"_version_":1663352135198179328,"score":170.85942},{"pmid":32277351,"title":"Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic.","text":["Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic.","Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has spread rapidly worldwide and has been shown to have a wide spectrum of severity. COVID-19 has become a public health emergency of relevant international concern, and it was declared a pandemic by the World Health Organization on 11 March, 2020. SARS-CoV-2 infection in severe cases involves the host response as an important contributor to the disease process and tissue damage, mainly due to dysregulated and excessive innate immune responses. The primary immune response leads to viral clearance in the majority of cases. However, in a subgroup of patients, the secondary immune response may be exaggerated, leading to inflammatory-induced lung injury and other complications including pneumonitis, acute respiratory distress syndrome, respiratory failure, shock, organ failure, and potentially death. Several cutaneous immune-mediated diseases, including psoriasis, atopic dermatitis, and hidradenitis suppurativa, are therapeutically managed with biologic and non-biologic immunosuppressive and immunomodulatory drugs. The outbreak of COVID-19 affects the management of these chronic conditions, not only for those who are already receiving treatment but also for those who are about to start a new treatment to control their disease. In this article, the management of cutaneous immune-mediated diseases during the COVID-19 pandemic is discussed.","Am J Clin Dermatol","Torres, Tiago","Puig, Luis","32277351"],"abstract":["Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has spread rapidly worldwide and has been shown to have a wide spectrum of severity. COVID-19 has become a public health emergency of relevant international concern, and it was declared a pandemic by the World Health Organization on 11 March, 2020. SARS-CoV-2 infection in severe cases involves the host response as an important contributor to the disease process and tissue damage, mainly due to dysregulated and excessive innate immune responses. The primary immune response leads to viral clearance in the majority of cases. However, in a subgroup of patients, the secondary immune response may be exaggerated, leading to inflammatory-induced lung injury and other complications including pneumonitis, acute respiratory distress syndrome, respiratory failure, shock, organ failure, and potentially death. Several cutaneous immune-mediated diseases, including psoriasis, atopic dermatitis, and hidradenitis suppurativa, are therapeutically managed with biologic and non-biologic immunosuppressive and immunomodulatory drugs. The outbreak of COVID-19 affects the management of these chronic conditions, not only for those who are already receiving treatment but also for those who are about to start a new treatment to control their disease. In this article, the management of cutaneous immune-mediated diseases during the COVID-19 pandemic is discussed."],"journal":"Am J Clin Dermatol","authors":["Torres, Tiago","Puig, Luis"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32277351","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s40257-020-00514-2","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664636943905849344,"score":162.44789}]}